Cancer Detection: Using Period Blood to Spot the Disease
Summary of the Article: New Diagnostic Potential in Menstrual & whole Blood
This article discusses emerging research and technologies focused on utilizing menstrual blood and whole blood (via a bandage sensor) for disease diagnosis. Here’s a breakdown of the key points:
1. Bandage-Based Whole Blood Analysis (Herrmann’s Research):
* A new sensor,developed by researchers,can analyze whole blood directly from a bandage - eliminating the need for a lab.
* The test uses a test strip that reacts with specific antibodies. The intensity of the resulting line indicates the concentration of biomarkers.
* It currently focuses on three biomarkers: CRP (inflammation), CEA (tumor marker), and CA-125 (endometriosis/ovarian cancer).
* The test can be read visually or with an app that uses machine learning for precise measurements.
* Researchers believe it can detect a wide range of diseases detectable in blood.
2. Menstrual Blood as a Diagnostic Tool (Blumenthal’s Research):
* Gynecologist Paul Blumenthal (Stanford University) has pioneered research into the diagnostic potential of menstrual blood.
* His studies have identified two key indicators in menstrual blood:
* High-risk HPV viruses: Linked to cervical cancer.
* Hemoglobin A1c: Used to diagnose and treat diabetes.
* Blumenthal emphasizes the health value of menstrual blood, challenging the perception of it as simply a waste product.
3. Femtech Start-ups & Commercialization:
* Several “femtech” start-ups, often led by women, are developing specialized blood tests based on menstrual blood.
* qvin (USA): Developing a ”Q-Pad” that detects health markers in menstrual blood, in collaboration with Blumenthal.
* Theblood (Germany): Developed an analysis method to diagnose diseases like diabetes and endometriosis using menstrual blood samples.
the article highlights a growing trend of recognizing menstrual blood and easily accessible whole blood as valuable sources for disease diagnosis, potentially revolutionizing healthcare through more convenient and accessible testing.